期刊文献+

结直肠癌肝转移患者生存情况及预后因素分析 被引量:9

Survival status and prognostic factors of liver metastases from colorectal cancer
原文传递
导出
摘要 目的探讨结直肠癌肝转移患者的生存情况及其预后相关因素。方法采用Kaplan—Meier和多因素回归分析方法,分析112例有完整随访资料的结直肠癌肝转移患者的生存情况及影响预后的相关因素。结果112例患者的中位生存时间为18.3个月,1、2、3和5年生存率分别为60.8%、35.0%、20.3%和4.8%。单因素分析显示,患者性别、年龄、原发肿瘤部位、化疗与否、肿瘤的病理类型与患者的总生存时间无关(P〉0.05),而原发肿瘤治疗方法、肝脏转移时间、原发肿瘤大体类型、肝脏转移灶手术与否和临床分期与患者的预后有关(P〈0.05)。多因素回归分析显示,肝脏转移灶手术与否、原发肿瘤大体类型和临床分期是影响结直肠癌肝转移患者预后的主要因素(P〈0.05)。结论对于结直肠癌肝转移的患者应积极切除肝转移病灶,延长患者生存时问。 Objective To analyze the survival status and prognostic factors of patients with liver metastases from colorectal cancer. Methods The survival rate and prognostic factors of 112 patients with liver metastases from colorectal cancer, who had complete follow-up data, were retrospectively assessed by Kaplan-Meier analysis and multivariate regression analysis. Results The median survival time of the 112 patients was 18.25 months. The 1-,2-,3- and 5-year overall survival rates were 60.8% , 35.0%, 20. 3% and 4.8%, respectively. Univariate analysis demonstrated that gender, age, primary tumor site, chemotherapy and pathological types had no significant correlation with the overall survival. But the treatment of primary tumor, time of liver metastasis, gross type of tumor, resection of liver metastases and clinical stage status were all independently related with the prognosis of patients. Multivariate regression analysis showed that resection of liver metastases, gross type of tumor and clinical stage were key factors affecting the prognosis of patients with liver metastases from colorectal cancer. Conclusion Patients with advanced stage, infiltrative gross type of coloreetal cancer should be followed-up closely so that liver metastases from the cancer can be diagnosed and treated early. Resection of both the primary tumor and liver metastasis may improve survival of the patients.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2010年第4期286-289,共4页 Chinese Journal of Oncology
关键词 结直肠肿瘤 肿瘤转移 预后 外科切除 Colorectal neoplasms Neoplasm metastasis Prognosis Surgical resection
  • 相关文献

参考文献16

  • 1Van Cutsem E,Nordlinger B,Adam R,et al.Towards a pan-European consensus on the treatment of patients with colorectal liver metastases.Eur J Cancer,2006,42:2212-2221.
  • 2Cohen AD,Kemeny NE.An update on hepatic arterial infusion chemotherapy for colorectal cancer.Oncologist,2003,8:553-566.
  • 3Choti MA,Sitzmann JV,Tiburi MF,et al.Trends in long-term survival following liver resection for hepatic colorectal metastases.Ann Surg,2002,235:759-766.
  • 4Vauthey JN,Zorzi D,Pawlik TM.Making unresectable hepatic colorectal metastases respectable:does it work? Semin Oncol,2005,32(6 Suppl 9):S118-122.
  • 5Adam R,Bismuth H,Castaing D,et al.Repeat hepatectomy for colorectal liver metastases.Ann Surg,1997,225:51-62.
  • 6Adam R,Delvart V,Pascal G,et al.Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy:a model to predict long-term survival.Ann Surg,2004,240:644-657.
  • 7Pawlik TM,Scoggins CR,Zorzi D,et al.Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.Ann Surg,2005,241:715-722.
  • 8Kemeny N.Management of liver metastases from colorectal cancer.Oncology(Williston Park),2006,20:1161-1176,1179.
  • 9Pozzo C,Basso M,Cassano A,et al.Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients.Ann Oncol,2004,15:933-939.
  • 10郝纯毅,沈琳,顾晋,邢宝才,张晓鹏,陆爱平,陈敏华,杨仁杰,李萍萍,季加孚.北京大学临床肿瘤学院大肠癌肝转移诊疗指南(2007)[J].中国实用外科杂志,2008,28(7):517-522. 被引量:24

二级参考文献34

  • 1Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer, 2002, 38:1023-1033.
  • 2Weber JC, Bachellier P, Oussoultzoglou E, et al. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg, 2003, 90:956-962.
  • 3Lyass S, Zamir G, Matot I, et al. Combined colon and hepatic resection for synchronous colorectal liver metastases. J Surg Oncol, 2001,78:17-21.
  • 4de Santibanes E, Lnssalle FB, McCormack L, et al. Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and long-term outcomes. J Am Coll Surg, 2002, 195 : 196-202.
  • 5Minagawa M, Yamamoto J, Miwa S, et al. Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg, 2006, 141:1006-1012.
  • 6Borner MM. Neoadjuvant chemotherapy for unresectable liver metastases colorectal cancer-too good to be true? Ann Oncol, 1999, 10: 623-626.
  • 7Fong Y, Blumgart LH. Hepatic colorectal metastasis : current status of surgical therapy. Oncology, 1998, 12:1489-1498.
  • 8Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer, 1996, 77:1254-1262.
  • 9Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg, 2000, 231:743-751.
  • 10Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg, 1995, 19:59-71.

共引文献25

同被引文献83

引证文献9

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部